Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$31.45

-0.635 (-1.98%)

07:46
08/29/18
08/29
07:46
08/29/18
07:46

Tesaro price target lowered to $85 from $100 at Citi

Citi analyst Robyn Karnauskas lowered her price target for Tesaro shares to $85 from $100 to reflect slowed penetration into medical oncologists and the most up-to-date market share data. The analyst sees catalysts for the stock in the "data-rich" second half of 2018 but thinks investors will have to watch and see if the changes Tesaro has implemented will increase its parp penetration. Karnauskas keeps a Buy rating on the shares.

  • 05

    Sep

  • 05

    Sep

  • 05

    Sep

TSRO Tesaro
$31.45

-0.635 (-1.98%)

08/06/18
08/06/18
DOWNGRADE
Target $35

Neutral
Tesaro downgraded to Neutral at BofA/Merrill
As previously reported, BofA/Merrill downgraded Tesaro to Neutral from Buy and slashed its price target to $35 from $72 following the Q2 report last week. Analyst Tazeen Ahmad said PARP inhibitor sales for maintenance treatment of ovarian cancer were below expectations and management lowered guidance citing the slower than expected ramp of the PARP class. Ahmad said physicians are deciding the right population and two other competitor drugs which is impacting uptake.
08/06/18
SBSH
08/06/18
NO CHANGE
Target $100
SBSH
Buy
Tesaro earnings pullback a buying opportunity, says Citi
Citi analyst Robyn Karnauskas views the post-earnings pullback in shares of Tesaro as a buying opportunity. While Zejula guidance was lowered for fiscal 2018, the SITC data remains a key catalyst, Karnauskas tells investors in a research note. She believes Lynparza approval likely in first line gBRCA maintenance and reiterates a Buy rating on Tesaro with a $100 price target.
08/15/18
ARGS
08/15/18
DOWNGRADE
ARGS
Hold
Tesaro downgraded to Hold from Buy at Argus
08/15/18
08/15/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nielsen (NLSN) downgraded to Hold from Buy at Pivotal Research with analyst Brian Wieser citing recent share strength following news of Elliott Investment Management's 8% stake in the company and maintained a $27 price target. 2. Union Pacific (UNP) downgraded to Hold from Buy at Deutsche Bank. 3. Kimberly-Clark (KMB) downgraded to Hold from Buy at Societe Generale with analyst Mitul Girotra saying pulp and oil input costs have risen sharply and cut his FY18 earnings estimate in line with management guidance. 4. Western Digital (WDC) downgraded to Market Perform from Outperform at Cowen with analyst Karl Ackerman saying his recent supply chain field work pointed to "substantial, unabated competitive pricing tactics" by the company and Toshiba (TOSBF) to gain share of enterprise and client solid state drives. 5. Tesaro (TSRO) downgraded to Hold from Buy at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

FDX

FedEx

$189.58

-3.36 (-1.74%)

07:47
12/12/18
12/12
07:47
12/12/18
07:47
Recommendations
FedEx analyst commentary  »

FedEx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

VST

Vistra Energy

$23.92

0.28 (1.18%)

07:45
12/12/18
12/12
07:45
12/12/18
07:45
Recommendations
Vistra Energy analyst commentary  »

Vistra Energy shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABIL

Ability

$2.37

0.005 (0.21%)

07:45
12/12/18
12/12
07:45
12/12/18
07:45
Hot Stocks
Ability regains Nasdaq compliance »

Ability announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARRY

Array BioPharma

$15.45

0.02 (0.13%)

07:44
12/12/18
12/12
07:44
12/12/18
07:44
Recommendations
Array BioPharma analyst commentary  »

Array BioPharma price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$18.02

0.02 (0.11%)

07:44
12/12/18
12/12
07:44
12/12/18
07:44
Initiation
iQIYI initiated  »

iQIYI initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THS

TreeHouse

$51.64

2.69 (5.50%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Recommendations
TreeHouse analyst commentary  »

TreeHouse price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPH

KemPharm

$2.78

0.07 (2.58%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Hot Stocks
KemPharm presents research on IV abuse potential of SDX at ACNP »

KemPharm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCCO

Southern Copper

$32.17

-0.08 (-0.25%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Downgrade
Southern Copper rating change  »

Southern Copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THS

TreeHouse

$51.64

2.69 (5.50%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Recommendations
TreeHouse analyst commentary  »

TreeHouse price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASR

Asur

$141.69

-0.66 (-0.46%)

07:42
12/12/18
12/12
07:42
12/12/18
07:42
Upgrade
Asur rating change  »

Asur upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$142.07

0.2 (0.14%)

, GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

07:42
12/12/18
12/12
07:42
12/12/18
07:42
Recommendations
Facebook, Alphabet Class A analyst commentary  »

Facebook testing search…

FB

Facebook

$142.07

0.2 (0.14%)

GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTM

Constellium

$8.12

0.2 (2.53%)

07:40
12/12/18
12/12
07:40
12/12/18
07:40
Conference/Events
Constellium to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 17

    Dec

  • 18

    Dec

ZLAB

Zai Lab

$19.93

-0.01 (-0.05%)

07:39
12/12/18
12/12
07:39
12/12/18
07:39
Hot Stocks
Zai Lab announces acceptance of Zejula NDA submission by NMPA »

Zai Lab announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$114.69

1.8 (1.59%)

07:39
12/12/18
12/12
07:39
12/12/18
07:39
Recommendations
Madrigal Pharmaceuticals analyst commentary  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$46.73

-0.85 (-1.79%)

07:38
12/12/18
12/12
07:38
12/12/18
07:38
Recommendations
Shake Shack analyst commentary  »

Shake Shack price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AEO

American Eagle

$19.03

-0.49 (-2.51%)

07:36
12/12/18
12/12
07:36
12/12/18
07:36
Recommendations
American Eagle analyst commentary  »

American Eagle shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$110.04

-0.78 (-0.70%)

07:36
12/12/18
12/12
07:36
12/12/18
07:36
Downgrade
Marriott rating change  »

Marriott downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$1.26

-0.04 (-3.08%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Hot Stocks
MYnd Analytics appoints Patrick Herguth CEO, George Carpenter CIO »

MYnd Analytics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.58

-0.17 (-0.69%)

, T

AT&T

$29.70

-0.21 (-0.70%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$24.58

-0.17 (-0.69%)

T

AT&T

$29.70

-0.21 (-0.70%)

NIO

NIO Inc.

$7.05

0.03 (0.43%)

BX

Blackstone

$30.50

0.03 (0.10%)

KHC

Kraft Heinz

$48.38

0.1 (0.21%)

NBR

Nabors Industries

$2.82

0.12 (4.44%)

KKR

KKR

$20.92

-0.21 (-0.99%)

TROX

Tronox

$7.11

0.06 (0.85%)

MLCO

Melco Resorts & Entertainment

$17.36

0.35 (2.06%)

DLPH

Delphi Technologies

$16.07

0.26 (1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 18

    Dec

  • 30

    Jan

  • 12

    Feb

  • 20

    Mar

07:35
12/12/18
12/12
07:35
12/12/18
07:35
General news
U.S. MBA mortgage market index rose 1.6% »

U.S. MBA mortgage market…

AUDVF

Audi AG

$0.00

(0.00%)

07:34
12/12/18
12/12
07:34
12/12/18
07:34
Hot Stocks
Audi names interim CEO Bram Schot as chairman of the board »

The Supervisory Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTB

Cooper Tire

$30.71

0.12 (0.39%)

07:34
12/12/18
12/12
07:34
12/12/18
07:34
Hot Stocks
Cooper Tire, Sailun announce JV for new TBR tire plant in Vietnam »

Cooper Tire & Rubber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDS

Aridis Pharmaceuticals

$7.96

0.02 (0.25%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Hot Stocks
Aridis Pharmaceuticals enrolls first subject in Phase 1/2a lung infection trial »

Aridis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$85.72

-0.14 (-0.16%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Hot Stocks
Neurocrine says valbenazine did not meet primary endpoint in Phase IIb study »

Neurocrine Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$66.30

0.58 (0.88%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.